Glenn W. Kaatz
The John D. Dingell Department of Veteran's Affairs Medical Center
Wayne State University School of Medicine
Detroit
MI 48201
USA
Name/email consistency: high
- Mechanisms of daptomycin resistance in Staphylococcus aureus. Kaatz, G.W., Lundstrom, T.S., Seo, S.M. Int. J. Antimicrob. Agents (2006)
- MepR, a repressor of the Staphylococcus aureus MATE family multidrug efflux pump MepA, is a substrate-responsive regulatory protein. Kaatz, G.W., DeMarco, C.E., Seo, S.M. Antimicrob. Agents Chemother. (2006)
- Effect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporter. Kaatz, G.W., Thyagarajan, R.V., Seo, S.M. Antimicrob. Agents Chemother. (2005)
- Bacterial efflux pump inhibition. Kaatz, G.W. Curr. Opin. Investig. Drugs (2005)
- Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein. Kaatz, G.W., McAleese, F., Seo, S.M. Antimicrob. Agents Chemother. (2005)
- Effect of substrate exposure and other growth condition manipulations on norA expression. Kaatz, G.W., Seo, S.M. J. Antimicrob. Chemother. (2004)
- Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus. Kaatz, G.W., Moudgal, V.V., Seo, S.M., Kristiansen, J.E. Antimicrob. Agents Chemother. (2003)
- Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus. Kaatz, G.W., Moudgal, V.V., Seo, S.M., Hansen, J.B., Kristiansen, J.E. Int. J. Antimicrob. Agents (2003)
- Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus. Kaatz, G.W., Moudgal, V.V., Seo, S.M. J. Antimicrob. Chemother. (2002)
- Inhibition of bacterial efflux pumps: a new strategy to combat increasing antimicrobial agent resistance. Kaatz, G.W. Expert. Opin. Emerg. Drugs (2002)
- Oxazolidinones: new players in the battle against multi-resistant Gram-positive bacteria. Kaatz, G.W., Rybak, M.J. Expert. Opin. Emerg. Drugs (2001)
- Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus. Kaatz, G.W., Seo, S.M., O'Brien, L., Wahiduzzaman, M., Foster, T.J. Antimicrob. Agents Chemother. (2000)
- Introduction of a norA promoter region mutation into the chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus using plasmid integration. Kaatz, G.W., Seo, S.M., Foster, T.J. Antimicrob. Agents Chemother. (1999)
- Topoisomerase mutations in fluoroquinolone-resistant and methicillin-susceptible and -resistant clinical isolates of Staphylococcus aureus. Kaatz, G.W., Seo, S.M. Antimicrob. Agents Chemother. (1998)
- Efficacy of trovafloxacin against experimental Staphylococcus aureus endocarditis. Kaatz, G.W., Seo, S.M., Aeschlimann, J.R., Houlihan, H.H., Mercier, R.C., Rybak, M.J. Antimicrob. Agents Chemother. (1998)
- Efficacy of LY333328 against experimental methicillin-resistant Staphylococcus aureus endocarditis. Kaatz, G.W., Seo, S.M., Aeschlimann, J.R., Houlihan, H.H., Mercier, R.C., Rybak, M.J. Antimicrob. Agents Chemother. (1998)
- Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus. Kaatz, G.W., Seo, S.M. Antimicrob. Agents Chemother. (1997)